bioSyntagma

Predictive analytics and biomarker discovery for treating cancer

David Richardson - Co-Founder and CEO, Dmitry Derkach MD, PhD - Chief Science Officer, Colleen Ziegler - Co-Founder, Director of Operations
1-10 employees
$1,200,000, Other
Phoenix
2015
B2B SaaS
Healthcare
Analytics and BI
Startup